Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidel

Showing results (601-610 of 715) with videos related to

Pageof 72
Sort By:
Leukemia|February 23, 2018
The cell fate determinant Scribble is required for maintenance of hematopoietic stem cell functionJuliane Mohr, Banaja P Dash, Tina M Schnoeder, et al.
Journal of Hematology & Oncology|July 16, 2020
Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapyJorge E Cortes, Florian H Heidel, Walter Fiedler, et al.
Oncotarget|December 10, 2017
<i>Protein phosphatase 4 regulatory subunit 2 (PPP4R2)</i> is recurrently deleted in acute myeloid leukemia and required for efficient DNA double strand break repairJulia K Herzig, Lars Bullinger, Alpaslan Tasdogan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2018
Bifunctional amyloid-reactive peptide promotes binding of antibody 11-1F4 to diverse amyloid types and enhances therapeutic efficacyJonathan S Wall, Angela D Williams, James S Foster, et al.
Leukemia|February 4, 2023
Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemiaJasmin Straube, Theresa Eifert, Therese Vu, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|August 30, 2020
Vascular plant extinction in the continental United States and CanadaWesley M Knapp, Anne Frances, Reed Noss, et al.
ACS Infectious Diseases|October 29, 2020
Antimicrobial Prodrug Activation by the Staphylococcal Glyoxalase GloBMarwa O Mikati, Justin J Miller, Damon M Osbourn, et al.
Oncoimmunology|August 16, 2025
Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitorsNora Möhn, Emily Narten, Laura Duzzi, et al.
Leukemia|February 24, 2023
Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)Frank Stegelmann, Lino L Teichmann, Florian H Heidel, et al.
ACS Infectious Diseases|March 12, 2026
Structure-Activity Relationships among Inhibitors of <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> 1-Deoxy-d-xylulose 5-Phosphate Reductoisomerase (DXR/IspC) - A Promising Target for Antibiotic DevelopmentMisgina Girma, Meagan Belcher Dufrisne, Archi Sehgal, et al.
Pageof 72

Showing results (601-610 of 715) with videos related to

Sort By:
Pageof 72
Leukemia|February 23, 2018
The cell fate determinant Scribble is required for maintenance of hematopoietic stem cell functionJuliane Mohr, Banaja P Dash, Tina M Schnoeder, et al.
Journal of Hematology & Oncology|July 16, 2020
Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapyJorge E Cortes, Florian H Heidel, Walter Fiedler, et al.
Oncotarget|December 10, 2017
<i>Protein phosphatase 4 regulatory subunit 2 (PPP4R2)</i> is recurrently deleted in acute myeloid leukemia and required for efficient DNA double strand break repairJulia K Herzig, Lars Bullinger, Alpaslan Tasdogan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2018
Bifunctional amyloid-reactive peptide promotes binding of antibody 11-1F4 to diverse amyloid types and enhances therapeutic efficacyJonathan S Wall, Angela D Williams, James S Foster, et al.
Leukemia|February 4, 2023
Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemiaJasmin Straube, Theresa Eifert, Therese Vu, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|August 30, 2020
Vascular plant extinction in the continental United States and CanadaWesley M Knapp, Anne Frances, Reed Noss, et al.
ACS Infectious Diseases|October 29, 2020
Antimicrobial Prodrug Activation by the Staphylococcal Glyoxalase GloBMarwa O Mikati, Justin J Miller, Damon M Osbourn, et al.
Oncoimmunology|August 16, 2025
Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitorsNora Möhn, Emily Narten, Laura Duzzi, et al.
Leukemia|February 24, 2023
Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)Frank Stegelmann, Lino L Teichmann, Florian H Heidel, et al.
ACS Infectious Diseases|March 12, 2026
Structure-Activity Relationships among Inhibitors of <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> 1-Deoxy-d-xylulose 5-Phosphate Reductoisomerase (DXR/IspC) - A Promising Target for Antibiotic DevelopmentMisgina Girma, Meagan Belcher Dufrisne, Archi Sehgal, et al.
Pageof 72